Caxton

Latest statistics and disclosures from Caxton Corp's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are GLD, BRK.B, SYRE, MNMD, KYTX, and represent 88.69% of Caxton Corp's stock portfolio.
  • Added to shares of these 4 stocks: SYRE, XFOR, BRK.B, IKT.
  • Started 2 new stock positions in XFOR, SYRE.
  • Reduced shares in these 9 stocks: RZLT (-$19M), ELVN, BCAX, MNMD, CMPX, GLD, KYTX, LXEO, SABS.
  • Sold out of its positions in BCAX, ELVN, RZLT.
  • Caxton Corp was a net seller of stock by $-19M.
  • Caxton Corp has $4.3M in assets under management (AUM), dropping by -81.28%.
  • Central Index Key (CIK): 0001388551

Tip: Access up to 7 years of quarterly data

Positions held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Caxton Corp

Caxton Corp holds 11 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Gold Tr Gold Shs (GLD) 64.5 $2.8M -4% 7.0k 396.31
 View chart
Berkshire Hathaway Inc Del Cl B New (BRK.B) 8.3 $357k +9% 710.00 502.49
 View chart
Spyre Therapeutics Com New (SYRE) 6.8 $292k NEW 8.9k 32.76
 View chart
Mind Medicine Mindmed Com New (MNMD) 4.9 $210k -41% 16k 13.39
 View chart
Kyverna Therapeutics (KYTX) 4.1 $177k -18% 19k 9.40
 View chart
Compass Therapeutics (CMPX) 3.7 $158k -44% 30k 5.37
 View chart
Lexeo Therapeutics (LXEO) 3.2 $139k -19% 14k 9.93
 View chart
X4 Pharmaceuticals Com New (XFOR) 1.5 $62k NEW 16k 4.00
 View chart
Inhibikase Therapeutics Com New (IKT) 1.4 $58k +73% 29k 2.05
 View chart
Sab Biotherapeutics Com New (SABS) 0.9 $39k -3% 11k 3.74
 View chart
Context Therapeutics (CNTX) 0.6 $27k 18k 1.47
 View chart

Past Filings by Caxton Corp

SEC 13F filings are viewable for Caxton Corp going back to 2013

View all past filings